Oculgen Biomedical Technology

Shenzhen Oculgen Biomedical Technology Co., Ltd. has successfully completed a Series A financing round, raising over RMB 100 million (USD 14.46 million). The round was led by LongRiver Jiangyuan Investment, with additional participation from Nanshan Zhanxin Investment, Junshi Venture Capital, Boyuan Capital, and Qingsong Capital. Existing investor Genesis Venture also…